Fungal Keratitis: Cipla, CSIR-CDRI’s New Venture
It is a serious eye infection that can lead to blindness. It is caused by fungi that invade the cornea, the transparent layer of the eye. It affects around 1.2 million people worldwide every year, especially in tropical countries where agricultural workers are at higher risk. The current therapies for fungal keratitis are not very […]
India Denies EU’s ‘Data Exclusivity’ for Drug Firms
India has refused to accept the demand of four European countries to include a data exclusivity provision in the proposed free trade agreements (FTA). The government said it will protect the interests of the domestic generic drug industry, which contributes to India’s exports and provides affordable medicines. What is data exclusivity? It is a form […]
AIIMS New Delhi Gets SBI SMART Payment Card
Patients visiting the All India Institute of Medical Sciences (AIIMS), New Delhi, can now avail the benefits of a smart payment card that will enable them to make cashless transactions at the hospital. The AIIMS-SBI SMART Payment Card was launched by Union Health Minister Dr. Mansukh Mandaviya on Monday, February 12, 2024, in collaboration with […]
Flywire and SBI Simplify Payments for Foreign Students
Indian students who want to pursue their education abroad can now enjoy a hassle-free and convenient payment process, thanks to the partnership between Flywire Corporation and State Bank of India (SBI), the largest lender in India. The partnership aims to offer Indian students an advanced digital checkout experience for their international educational payments, ranging from […]
Think Health Diagnostics: New Acquisition by Thyrocare
Thyrocare, a leading diagnostic and preventive healthcare service provider in India, has acquired Think Health Diagnostics, a home healthcare technology company that offers ECG services at home. The deal was announced on February 1, 2024, and will make Thyrocare one of the largest diagnostics at home healthcare service providers in India. Why Thyrocare acquired Think […]
Cipla Targets Acquisitions, Partnerships in US Market
Cipla, one of the leading pharmaceutical companies in India, is looking for opportunities to expand its presence in the US market through acquisitions and inorganic partnerships. The company is also focusing on improving its top line growth in Europe and margin expansion in South Africa. The US market is a key strategic area for Cipla, […]
Ayushman Bharat to Cover ASHA, Anganwadi Workers: FM
In a major announcement in the interim budget 2024, Finance Minister Nirmala Sitharaman said that the Ayushman Bharat scheme, which provides health insurance to the poor and vulnerable, will be extended to all ASHA and Anganwadi workers and helpers. This will benefit about 30 lakh frontline health workers who are involved in delivering essential services […]
Glenmark Pharma, Ichnos Launch Alliance
Glenmark Pharmaceuticals Ltd. and its subsidiary, Ichnos Sciences Inc., have announced the launch of their alliance, Ichnos Glenmark Innovation (IGI), to accelerate new drug discovery in cancer treatment. This alliance combines Glenmark’s research and development proficiencies in small molecules with those of Ichnos in novel biologics to continue developing cutting-edge therapy solutions that treat hematological […]
Zydus Launches New Pill for Prostate Cancer
Zydus Lifesciences Ltd., a global innovation driven healthcare company, has announced the launch of Rexigo™, a new oral once-a-day pill for testosterone suppression in patients with advanced prostate cancer. The drug is the first and only generic version of Relugolix, which has been available in developed countries since 2020. Prostate cancer is one of the […]
Glenmark, Jiangsu Alphamab, 3D Medicines Sign Cancer Drug Pact
Glenmark Pharmaceuticals Ltd., a leading Indian drugmaker, has secured an exclusive license to develop and commercialize a novel cancer drug in several emerging markets. The drug, known as Envafolimab or KN035, is a subcutaneous injection of PD-L1 antibody that can be administered at home or in outpatient settings. Envafolimab is being developed by Jiangsu Alphamab […]